Search research articles
Contact Us
Filters
Showing results (91-100 of 101) with videos related to
Page
of 11
Sort By:
Blood Advances
|
October 6, 2021
Adding venetoclax to fludarabine/busulfan RIC transplant for high-risk MDS and AML is feasible, safe, and active
Jacqueline S Garcia, Haesook T Kim, H Moses Murdock, et al.
Biochemistry
|
July 6, 2005
Biochemical and structural characterization of a novel class of inhibitors of the type 1 insulin-like growth factor and insulin receptor kinases
Ian M Bell, Steven M Stirdivant, Janet Ahern, et al.
Journal of the National Cancer Institute
|
April 12, 2023
Clonal hematopoiesis in older patients with breast cancer receiving chemotherapy
Christina Mayerhofer, Mina S Sedrak, Judith O Hopkins, et al.
Blood
|
March 18, 2026
Discovery and preclinical activity of the menin-KMT2A inhibitor ziftomenib in acute leukemia models
Hongzhi Miao, Tao Wu, Trupta Purohit, et al.
Blood Advances
|
May 26, 2023
Current clinical practices and challenges in molecular testing: a GOAL Consortium Hematopathology Working Group report
Thomas D Lee, Dara L Aisner, Marjorie P David, et al.
Blood Advances
|
May 2, 2022
Metformin for treatment of cytopenias in children and young adults with Fanconi anemia
Jessica A Pollard, Elissa Furutani, Shanshan Liu, et al.
JCO Oncology Practice
|
September 8, 2023
Optimization of Advanced Molecular Genetic Testing Utilization in Hematopathology: A Goldilocks Approach to Bone Marrow Testing
Ali AlJabban, Henry Paik, Jon C Aster, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 19, 2023
Integration of Genomic Sequencing Drives Therapeutic Targeting of PDGFRA in T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
Jonathan Paolino, Boris Dimitrov, Beth Apsel Winger, et al.
Blood
|
September 21, 2022
Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia
Eric J Duncavage, Adam Bagg, Robert P Hasserjian, et al.
Cancer Discovery
|
February 10, 2021
Matched Targeted Therapy for Pediatric Patients with Relapsed, Refractory, or High-Risk Leukemias: A Report from the LEAP Consortium
Yana Pikman, Sarah K Tasian, Maria Luisa Sulis, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 101) with videos related to
Sort By:
Page
of 11
Blood Advances
|
October 6, 2021
Adding venetoclax to fludarabine/busulfan RIC transplant for high-risk MDS and AML is feasible, safe, and active
Jacqueline S Garcia, Haesook T Kim, H Moses Murdock, et al.
Biochemistry
|
July 6, 2005
Biochemical and structural characterization of a novel class of inhibitors of the type 1 insulin-like growth factor and insulin receptor kinases
Ian M Bell, Steven M Stirdivant, Janet Ahern, et al.
Journal of the National Cancer Institute
|
April 12, 2023
Clonal hematopoiesis in older patients with breast cancer receiving chemotherapy
Christina Mayerhofer, Mina S Sedrak, Judith O Hopkins, et al.
Blood
|
March 18, 2026
Discovery and preclinical activity of the menin-KMT2A inhibitor ziftomenib in acute leukemia models
Hongzhi Miao, Tao Wu, Trupta Purohit, et al.
Blood Advances
|
May 26, 2023
Current clinical practices and challenges in molecular testing: a GOAL Consortium Hematopathology Working Group report
Thomas D Lee, Dara L Aisner, Marjorie P David, et al.
Blood Advances
|
May 2, 2022
Metformin for treatment of cytopenias in children and young adults with Fanconi anemia
Jessica A Pollard, Elissa Furutani, Shanshan Liu, et al.
JCO Oncology Practice
|
September 8, 2023
Optimization of Advanced Molecular Genetic Testing Utilization in Hematopathology: A Goldilocks Approach to Bone Marrow Testing
Ali AlJabban, Henry Paik, Jon C Aster, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 19, 2023
Integration of Genomic Sequencing Drives Therapeutic Targeting of PDGFRA in T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
Jonathan Paolino, Boris Dimitrov, Beth Apsel Winger, et al.
Blood
|
September 21, 2022
Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia
Eric J Duncavage, Adam Bagg, Robert P Hasserjian, et al.
Cancer Discovery
|
February 10, 2021
Matched Targeted Therapy for Pediatric Patients with Relapsed, Refractory, or High-Risk Leukemias: A Report from the LEAP Consortium
Yana Pikman, Sarah K Tasian, Maria Luisa Sulis, et al.
Page
of 11